Markus Schürks1, Pamela M Rist, Robert E Shapiro, Tobias Kurth. 1. Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston, MA 02215–1204, USA. markus.schuerks@post.harvard.edu
Abstract
OBJECTIVE: To evaluate the evidence on the association between migraine and mortality. METHODS: Systematic review and meta-analysis of studies investigating the association between any migraine (all forms of migraine collectively) or migraine subtypes (e.g. migraine with aura) and mortality published until March 2011. RESULTS: We identified ten cohort studies. Studies differed regarding the types of mortality investigated and only four presented aura-stratified results, limiting pooled analyses with regard to migraine subtypes and with regard to cause-specific mortality. For any migraine pooled analyses do not suggest an association with all-cause mortality (five studies; pooled relative risk (RR)=0.90, 95% confidence interval (CI) 0.71-1.16), cardiovascular disease mortality (CVD; six studies; pooled RR=1.09, 95% CI 0.89-1.32), or coronary heart disease mortality (CHD; three studies; pooled RR=0.95, 95% CI 0.57-1.60). Heterogeneity among studies is moderate to high. Two studies suggest that migraine with aura increases risk for CVD and CHD mortality. CONCLUSION: This meta-analysis does not suggest that any migraine is associated with increased risk of mortality from all causes, CVD, or CHD. However, there is heterogeneity among studies and suggestion that migraine with aura increases CVD and CHD mortality. Given the high prevalence of migraine in the general population a definitive answer to the question of whether migraine or a subtype alters risk for mortality is of high public health importance and further targeted research implicated.
OBJECTIVE: To evaluate the evidence on the association between migraine and mortality. METHODS: Systematic review and meta-analysis of studies investigating the association between any migraine (all forms of migraine collectively) or migraine subtypes (e.g. migraine with aura) and mortality published until March 2011. RESULTS: We identified ten cohort studies. Studies differed regarding the types of mortality investigated and only four presented aura-stratified results, limiting pooled analyses with regard to migraine subtypes and with regard to cause-specific mortality. For any migraine pooled analyses do not suggest an association with all-cause mortality (five studies; pooled relative risk (RR)=0.90, 95% confidence interval (CI) 0.71-1.16), cardiovascular disease mortality (CVD; six studies; pooled RR=1.09, 95% CI 0.89-1.32), or coronary heart disease mortality (CHD; three studies; pooled RR=0.95, 95% CI 0.57-1.60). Heterogeneity among studies is moderate to high. Two studies suggest that migraine with aura increases risk for CVD and CHD mortality. CONCLUSION: This meta-analysis does not suggest that any migraine is associated with increased risk of mortality from all causes, CVD, or CHD. However, there is heterogeneity among studies and suggestion that migraine with aura increases CVD and CHD mortality. Given the high prevalence of migraine in the general population a definitive answer to the question of whether migraine or a subtype alters risk for mortality is of high public health importance and further targeted research implicated.
Authors: Nancy R Cook; Isabela M Benseñor; Paulo A Lotufo; I-Min Lee; Patrick J Skerrett; Marilyn J Chown; Umed A Ajani; JoAnn E Manson; Julie E Buring Journal: Headache Date: 2002-09 Impact factor: 5.887
Authors: Dale R Nyholt; Nathan G Gillespie; Andrew C Heath; Kathleen R Merikangas; David L Duffy; Nicholas G Martin Journal: Genet Epidemiol Date: 2004-04 Impact factor: 2.135
Authors: Elles J Mulder; Caroline Van Baal; David Gaist; Mikko Kallela; Jaakko Kaprio; Dan A Svensson; Dale R Nyholt; Nicholas G Martin; Alex J MacGregor; Lynn F Cherkas; Dorret I Boomsma; Aarno Palotie Journal: Twin Res Date: 2003-10
Authors: Ann I Scher; Gudny Eiriksdottir; Melissa Garcia; Preethy Feit; Albert V Smith; Tamara B Harris; Kathryn A Roecklein; Larus S Gudmundsson; Vilmundur Gudnason; Lenore J Launer Journal: Cephalalgia Date: 2012-12-10 Impact factor: 6.292
Authors: Maulik P Purohit; Ross D Zafonte; Laura M Sherman; Roger B Davis; Michelle Y Giwerc; Martha E Shenton; Gloria Y Yeh Journal: J Clin Psychiatry Date: 2015-07 Impact factor: 4.384
Authors: Maulik P Purohit; Rebecca Erwin Wells; Ross Zafonte; Roger B Davis; Gloria Y Yeh; Russell S Phillips Journal: J Clin Psychiatry Date: 2013-06 Impact factor: 4.384